| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocephalus | 7 | 2022 | 40 | 2.300 |
Why?
|
| Neurosurgical Procedures | 4 | 2022 | 98 | 1.460 |
Why?
|
| Intracranial Hypertension | 3 | 2022 | 53 | 1.200 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2022 | 2223 | 1.170 |
Why?
|
| Brain | 6 | 2021 | 2176 | 0.900 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2022 | 3 | 0.850 |
Why?
|
| Hemangioma, Cavernous | 1 | 2022 | 5 | 0.840 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 6 | 0.840 |
Why?
|
| Megalencephaly | 1 | 2022 | 3 | 0.830 |
Why?
|
| Subdural Space | 1 | 2022 | 5 | 0.830 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2022 | 85 | 0.790 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2022 | 446 | 0.710 |
Why?
|
| Central Nervous System Cysts | 1 | 2019 | 5 | 0.700 |
Why?
|
| Neuroimaging | 1 | 2021 | 122 | 0.680 |
Why?
|
| Siblings | 1 | 2019 | 34 | 0.680 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 105 | 0.660 |
Why?
|
| Fasciitis | 1 | 2019 | 30 | 0.650 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 50 | 0.640 |
Why?
|
| Blood Glucose | 1 | 2022 | 631 | 0.640 |
Why?
|
| Head | 1 | 2019 | 59 | 0.630 |
Why?
|
| Child | 15 | 2022 | 6405 | 0.630 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2020 | 6 | 0.610 |
Why?
|
| Radiation | 1 | 2016 | 7 | 0.570 |
Why?
|
| Medulloblastoma | 1 | 2016 | 24 | 0.560 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 189 | 0.560 |
Why?
|
| Models, Neurological | 1 | 2017 | 136 | 0.550 |
Why?
|
| HLA Antigens | 1 | 2016 | 82 | 0.550 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 807 | 0.550 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2016 | 44 | 0.520 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 42 | 0.510 |
Why?
|
| Astrocytes | 1 | 2017 | 270 | 0.500 |
Why?
|
| Meningioma | 1 | 2015 | 54 | 0.500 |
Why?
|
| Diagnostic Imaging | 1 | 2016 | 201 | 0.500 |
Why?
|
| Humans | 32 | 2022 | 68618 | 0.480 |
Why?
|
| Infant | 5 | 2022 | 2891 | 0.470 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 511 | 0.460 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2013 | 21 | 0.440 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2014 | 137 | 0.440 |
Why?
|
| Elective Surgical Procedures | 1 | 2013 | 95 | 0.440 |
Why?
|
| Intracranial Pressure | 1 | 2013 | 58 | 0.430 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 211 | 0.420 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 756 | 0.410 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 36 | 0.410 |
Why?
|
| Skull | 3 | 2021 | 63 | 0.400 |
Why?
|
| Neurons | 1 | 2017 | 881 | 0.400 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1851 | 0.400 |
Why?
|
| Drainage | 1 | 2012 | 133 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 772 | 0.390 |
Why?
|
| White Matter | 1 | 2014 | 174 | 0.390 |
Why?
|
| Gliosis | 1 | 2011 | 51 | 0.390 |
Why?
|
| Syringomyelia | 2 | 2021 | 4 | 0.380 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 142 | 0.380 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2021 | 8 | 0.380 |
Why?
|
| Cats | 4 | 2014 | 292 | 0.370 |
Why?
|
| Decompression, Surgical | 3 | 2021 | 55 | 0.370 |
Why?
|
| Brain Injuries | 1 | 2013 | 268 | 0.350 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2020 | 16 | 0.340 |
Why?
|
| Animals, Newborn | 4 | 2022 | 396 | 0.340 |
Why?
|
| Time Factors | 5 | 2017 | 4655 | 0.340 |
Why?
|
| Female | 19 | 2022 | 38074 | 0.340 |
Why?
|
| Retrospective Studies | 6 | 2022 | 7277 | 0.330 |
Why?
|
| Child, Preschool | 3 | 2021 | 3187 | 0.320 |
Why?
|
| Male | 19 | 2022 | 37321 | 0.310 |
Why?
|
| Adolescent | 6 | 2021 | 8912 | 0.310 |
Why?
|
| Prognosis | 4 | 2022 | 2093 | 0.290 |
Why?
|
| Meningomyelocele | 2 | 2017 | 11 | 0.280 |
Why?
|
| Basilar Artery | 2 | 2016 | 38 | 0.270 |
Why?
|
| Seizures | 2 | 2019 | 279 | 0.260 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 1140 | 0.250 |
Why?
|
| Stroke | 4 | 2020 | 2163 | 0.250 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2016 | 134 | 0.250 |
Why?
|
| Infant, Newborn | 3 | 2021 | 2455 | 0.240 |
Why?
|
| Cell Survival | 2 | 2017 | 901 | 0.240 |
Why?
|
| Survival Analysis | 2 | 2016 | 714 | 0.220 |
Why?
|
| Thrombectomy | 2 | 2016 | 238 | 0.220 |
Why?
|
| Pediatrics | 2 | 2016 | 341 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2324 | 0.220 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2022 | 10 | 0.210 |
Why?
|
| Neural Pathways | 1 | 2004 | 324 | 0.210 |
Why?
|
| Subarachnoid Space | 1 | 2022 | 7 | 0.210 |
Why?
|
| Pons | 1 | 2022 | 35 | 0.210 |
Why?
|
| Hematoma, Subdural | 1 | 2022 | 19 | 0.210 |
Why?
|
| Hypertrophy | 1 | 2022 | 89 | 0.200 |
Why?
|
| Hydroxyapatites | 1 | 2021 | 10 | 0.200 |
Why?
|
| Skull Fractures | 1 | 2021 | 17 | 0.200 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 415 | 0.190 |
Why?
|
| Dura Mater | 1 | 2021 | 23 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2550 | 0.190 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2021 | 37 | 0.190 |
Why?
|
| Manipulation, Chiropractic | 1 | 2020 | 3 | 0.180 |
Why?
|
| Internal Fixators | 1 | 2020 | 23 | 0.180 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 150 | 0.180 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 366 | 0.180 |
Why?
|
| Atlanto-Axial Joint | 1 | 2020 | 13 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 198 | 0.180 |
Why?
|
| Scoliosis | 1 | 2020 | 42 | 0.180 |
Why?
|
| Spinal Fusion | 1 | 2021 | 90 | 0.170 |
Why?
|
| Optic Nerve Diseases | 1 | 2019 | 31 | 0.170 |
Why?
|
| Nausea | 1 | 2019 | 47 | 0.170 |
Why?
|
| Headache | 1 | 2019 | 68 | 0.170 |
Why?
|
| Joint Instability | 1 | 2020 | 87 | 0.170 |
Why?
|
| Stroke Volume | 1 | 2022 | 586 | 0.170 |
Why?
|
| Fascia | 1 | 2019 | 17 | 0.170 |
Why?
|
| Treatment Outcome | 6 | 2021 | 7029 | 0.160 |
Why?
|
| Vision Disorders | 1 | 2019 | 94 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 481 | 0.160 |
Why?
|
| Prevalence | 1 | 2022 | 1619 | 0.150 |
Why?
|
| Pedigree | 1 | 2017 | 159 | 0.150 |
Why?
|
| Middle Aged | 6 | 2022 | 21147 | 0.150 |
Why?
|
| Iran | 2 | 2014 | 12 | 0.150 |
Why?
|
| Hydrogels | 1 | 2017 | 54 | 0.140 |
Why?
|
| 4-1BB Ligand | 1 | 2016 | 5 | 0.140 |
Why?
|
| Adult | 5 | 2022 | 21403 | 0.140 |
Why?
|
| Echoencephalography | 1 | 2016 | 10 | 0.140 |
Why?
|
| Pressure | 1 | 2017 | 252 | 0.140 |
Why?
|
| Ventriculostomy | 1 | 2016 | 7 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 52 | 0.140 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2016 | 84 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 261 | 0.140 |
Why?
|
| Tissue Scaffolds | 1 | 2017 | 111 | 0.140 |
Why?
|
| Animals | 7 | 2022 | 20881 | 0.140 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 314 | 0.130 |
Why?
|
| Immunoglobulin Light-chain Amyloidosis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Radial Neuropathy | 1 | 2016 | 2 | 0.130 |
Why?
|
| Caspase 3 | 1 | 2016 | 233 | 0.130 |
Why?
|
| Equipment Design | 1 | 2017 | 500 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 129 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 219 | 0.130 |
Why?
|
| Executive Function | 1 | 2016 | 106 | 0.130 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 109 | 0.130 |
Why?
|
| Memory | 1 | 2016 | 214 | 0.120 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2016 | 138 | 0.120 |
Why?
|
| Optic Tract | 1 | 2014 | 1 | 0.120 |
Why?
|
| Internal Capsule | 1 | 2014 | 7 | 0.120 |
Why?
|
| Optic Chiasm | 1 | 2014 | 3 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2016 | 432 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2014 | 29 | 0.120 |
Why?
|
| Mean Platelet Volume | 1 | 2014 | 1 | 0.120 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2016 | 134 | 0.120 |
Why?
|
| Anisotropy | 1 | 2014 | 105 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 49 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 499 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 1040 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 99 | 0.120 |
Why?
|
| Cardiology Service, Hospital | 1 | 2013 | 11 | 0.120 |
Why?
|
| Disease Progression | 2 | 2022 | 1038 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 306 | 0.110 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2013 | 3 | 0.110 |
Why?
|
| Brachial Plexus | 1 | 2013 | 15 | 0.110 |
Why?
|
| Nerve Transfer | 1 | 2013 | 5 | 0.110 |
Why?
|
| Medically Underserved Area | 1 | 2013 | 85 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 839 | 0.110 |
Why?
|
| Paralysis | 1 | 2013 | 35 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2021 | 1615 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 2013 | 45 | 0.110 |
Why?
|
| Kaolin | 1 | 2012 | 23 | 0.100 |
Why?
|
| Cognition | 1 | 2016 | 513 | 0.100 |
Why?
|
| Aged | 2 | 2022 | 14862 | 0.100 |
Why?
|
| Acute Coronary Syndrome | 1 | 2014 | 195 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2673 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2012 | 107 | 0.100 |
Why?
|
| Motor Skills | 1 | 2012 | 88 | 0.100 |
Why?
|
| Risk Factors | 1 | 2022 | 5731 | 0.100 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 253 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 92 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1851 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 689 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2013 | 622 | 0.090 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2011 | 1664 | 0.090 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 26 | 0.090 |
Why?
|
| Brain Ischemia | 1 | 2016 | 665 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2016 | 2007 | 0.090 |
Why?
|
| Actins | 1 | 2011 | 249 | 0.090 |
Why?
|
| Carotid Artery, Internal | 1 | 2010 | 85 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2013 | 1451 | 0.070 |
Why?
|
| Maternal Deprivation | 2 | 2003 | 4 | 0.070 |
Why?
|
| Desipramine | 2 | 2003 | 47 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1293 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2013 | 3705 | 0.060 |
Why?
|
| Efferent Pathways | 1 | 2004 | 15 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2004 | 31 | 0.060 |
Why?
|
| Models, Animal | 1 | 2004 | 252 | 0.060 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2003 | 24 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2022 | 2083 | 0.050 |
Why?
|
| Cerebral Angiography | 2 | 2016 | 151 | 0.050 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2003 | 79 | 0.050 |
Why?
|
| Motor Cortex | 1 | 2004 | 158 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 2358 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2002 | 74 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2002 | 81 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2002 | 173 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2021 | 80 | 0.050 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 24 | 0.050 |
Why?
|
| Transplants | 1 | 2021 | 28 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 122 | 0.050 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 145 | 0.050 |
Why?
|
| Magnetics | 1 | 2020 | 52 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2020 | 112 | 0.040 |
Why?
|
| Rats | 3 | 2022 | 5300 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2017 | 597 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2017 | 21 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 365 | 0.040 |
Why?
|
| Recurrence | 1 | 2020 | 948 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1753 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 514 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2017 | 159 | 0.030 |
Why?
|
| Intelligence | 1 | 2016 | 45 | 0.030 |
Why?
|
| Verapamil | 1 | 2016 | 30 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2015 | 18 | 0.030 |
Why?
|
| Language | 1 | 2016 | 120 | 0.030 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2015 | 32 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2002 | 824 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 138 | 0.030 |
Why?
|
| Leiomyoma | 1 | 2014 | 28 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 517 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2014 | 100 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 951 | 0.030 |
Why?
|
| Radial Nerve | 1 | 2013 | 2 | 0.030 |
Why?
|
| Deltoid Muscle | 1 | 2013 | 2 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 392 | 0.030 |
Why?
|
| Movement Disorders | 1 | 2013 | 58 | 0.030 |
Why?
|
| Acute Disease | 1 | 2014 | 658 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2002 | 1242 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 800 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2014 | 601 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 1465 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 8474 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 396 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2010 | 109 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3259 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 4848 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 5717 | 0.020 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 2002 | 12 | 0.010 |
Why?
|
| RNA Probes | 1 | 2002 | 15 | 0.010 |
Why?
|
| Densitometry | 1 | 2002 | 15 | 0.010 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2002 | 10 | 0.010 |
Why?
|
| Adrenal Cortex | 1 | 2002 | 8 | 0.010 |
Why?
|
| Autoradiography | 1 | 2002 | 94 | 0.010 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2002 | 45 | 0.010 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2002 | 51 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 201 | 0.010 |
Why?
|
| Nerve Net | 1 | 2003 | 181 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 290 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 370 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 2334 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 1330 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 805 | 0.010 |
Why?
|